New agents for induction and postremission therapy of acute myeloid leukemia

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.

Leukemia·2020

Treatment of horizontal silage bunker runoff using biochar amended vegetative filter strips.

Journal of environmental management·2019

Nitrate sorption to biochar following chemical oxidation.

The Science of the total environment·2019

Constraining the Spatial Extent of Marine Oil Snow Sedimentation and Flocculent Accumulation Following the Deepwater Horizon Event Using an Excess 210Pb Flux Approach.

Environmental science & technology·2017

The impact of biogas and fuelwood use on institutional kitchen air quality in Kampala, Uganda.

Indoor air·2017

Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503).

Leukemia·2016

Tisa-cel and axi-cel CAR structure influences the development of resistance to CD19-CAR-T therapy.

Leukemia·2026

Cheminformatic identification of small molecules targeting acute myeloid leukemia.

Leukemia·2026

Ivosidenib monotherapy in IDH1 mutated myelodysplastic neoplasm/syndrome.

Leukemia·2026

Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis.

Leukemia·2026

PTBP1 controls oncogenic transcript processing and maintenance of acute myeloid leukemia.

Leukemia·2026

TP53-mutant CHIP defines a pro-inflammatory phenotype and predicts adverse outcomes after CAR T-cell therapy.

Leukemia·2026

Light Source-Dependent Photooxidation of Therapeutic Monoclonal Antibodies: A Comparative Study of Light-Emitting Diode (LED) and Fluorescent Exposure.

Pharmaceutical development and technology·2026

Single-cell immune profiling of blood and thrombus in cancer-associated thrombosis.

iScience·2026

BCR::ABL1 e1a2 (p190)-Positive Myeloid Blast Neoplasm: Diagnostic Challenges in Distinguishing De Novo Acute Myeloid Leukemia From Previously Unrecognized Chronic Myeloid Leukemia in the Blast Phase.

Cureus·2026

Myeloid sarcoma as EM blast crisis in BCR-ABL1 e6a2+ CML with myelofibrosis and TB: a case report.

Open life sciences·2026

Long-term results of the HD0607 trial on interim PET-adapted treatment of advanced-stage Hodgkin lymphoma beyond 10 years of follow-up.

EClinicalMedicine·2026

Related Experiment Videos

New agents for induction and postremission therapy of acute myeloid leukemia

Related Concept Videos

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.

Treatment of horizontal silage bunker runoff using biochar amended vegetative filter strips.

Nitrate sorption to biochar following chemical oxidation.

Constraining the Spatial Extent of Marine Oil Snow Sedimentation and Flocculent Accumulation Following the Deepwater Horizon Event Using an Excess 210Pb Flux Approach.

The impact of biogas and fuelwood use on institutional kitchen air quality in Kampala, Uganda.

Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503).

Tisa-cel and axi-cel CAR structure influences the development of resistance to CD19-CAR-T therapy.

Cheminformatic identification of small molecules targeting acute myeloid leukemia.

Ivosidenib monotherapy in IDH1 mutated myelodysplastic neoplasm/syndrome.

Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis.

PTBP1 controls oncogenic transcript processing and maintenance of acute myeloid leukemia.

TP53-mutant CHIP defines a pro-inflammatory phenotype and predicts adverse outcomes after CAR T-cell therapy.

Light Source-Dependent Photooxidation of Therapeutic Monoclonal Antibodies: A Comparative Study of Light-Emitting Diode (LED) and Fluorescent Exposure.

Single-cell immune profiling of blood and thrombus in cancer-associated thrombosis.

BCR::ABL1 e1a2 (p190)-Positive Myeloid Blast Neoplasm: Diagnostic Challenges in Distinguishing De Novo Acute Myeloid Leukemia From Previously Unrecognized Chronic Myeloid Leukemia in the Blast Phase.

Myeloid sarcoma as EM blast crisis in BCR-ABL1 e6a2+ CML with myelofibrosis and TB: a case report.

Long-term results of the HD0607 trial on interim PET-adapted treatment of advanced-stage Hodgkin lymphoma beyond 10 years of follow-up.

Related Experiment Videos

New agents for induction and postremission therapy of acute myeloid leukemia

Related Concept Videos

Related Articles